Reading time is 2 mins
.
.
BIG CONCERN IN CORONA VIRUS VACCINE
Emergent BioSolutions, which produces the Covid-19 vaccine developed by Johnson & Johnson in Baltimore, USA, has disrupted the vaccine process in Europe, South Africa and Canada due to manufacturing errors and quality control problems.
Emergent BioSolutions, which produces Johnson & Johnson’s vaccines in Baltimore, USA, is experiencing a problem in the field of quality control, on the agenda of the international public…
First reported by the New York Times, It was announced that quality control problems in the production process of Emergent BioSolutions had negatively affected the vaccination process in Europe, South Africa and Canada.
.
THESE VACCINES ARE BEING SENT TO OTHER COUNTRIES
The distribution of millions of Johnson & Johnson vaccines has been stopped in all three regions, while the vaccines produced at this plant have not received approval from the Food and Drug Administration, a major U.S. Health Organization. U.S. President Joe Biden has also said in the past that Johnson & Johnson vaccines produced at this plant are not used in the country and that these vaccines are imported.
But because of this safety weakness, millions of doses were found to be waiting in Canada, the European Union and South Africa. In March, it was revealed that Johnson & Johnson’s vaccine at the factory in Baltimore had been added to harmless viruses used in the production of AstraZeneca’s vaccine, and 15 million doses of the vaccine had been trashed in the wake of this crisis.
.
BIG PROBLEM IN SOUTH AFRICA
“We have examined some samples of the vaccine produced at Emergent and we do not see a problem,” EU officials said, while Canadian and South African officials, along with EU officials, said there was no indication that the vaccines they had were damaged or damaged. But officials also announced that the vaccines had been put on hold.
But the U.S. Food and Drug Administration (FDA) also said that reviews are continuing for about 70 million doses to be used inside the United States, and that these vaccines may not be good enough to be used in the United States. Speaking to the New York Times, an FDA spokesperson said, “We are currently in contact with foreign agencies and organizations and are examining the situation. Other countries import medicines and vaccines according to their own standards,” he said.
Johnson & Johnson’s vaccine crisis is going to be a big problem in a country like South Africa that is experiencing a vaccine crisis and has a low vaccination rate across the community, or in countries like Canada that put a four-month period between two-dose vaccines.
.
.
.
Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.
Physician's Resume:
Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.
Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.
In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.
Awards:
Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.
Certificates:
Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .
Professional Members:
American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.
Disclaimer:
Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
- CRANIOCERVICAL SYNDROME MISALIGNMENT IN THE UPPER CERVICAL REGION - 16/04/2024
- MISALIGNMENT OF THE UPPER CERVICAL BONES (C1-C2) - 16/04/2024
- WHAT IS GLOSSOPHARYNGEAL NEURALGIA (SORE THROAT)? - 16/04/2024